Treatment of gynoid lipodystrophy
AssigneeMERZ PHARMA GmbH & CO. KGaA
InventorsHarry Frank ABST, Rainer POOTH, Martina KERSCHER, Thomas HENGL, Birgit BLESSMANN-GURK, Sabine OTTO
Life of this patent
Estimating the term…
Abstract
The present invention generally relates to the treatment of gynoid lipodystrophy, and more specifically to the use of calcium (hydroxy)phosphate particles in combination with at least one compound capable of reducing local subcutaneous fat in the treatment of gynoid lipodystrophy.
Claims15
A product comprising calcium (hydroxy)phosphate particles in combination with at least one compound capable of reducing local subcutaneous fat in treatment of gynoid lipodystrophy.
A method for treating gynoid lipodystrophy comprising administering to a subject in need thereof an effective amount of calcium (hydroxy)phosphate particles and an effective amount of at least one compound capable of reducing local subcutaneous fat, wherein the calcium (hydroxy)phosphate particles are administered concurrently, sequentially or separately with the at least one compound capable of reducing local subcutaneous fat.
Dependencies are inferred from the claim text.